The primary advantage is the reduction of side effects, as healthy cells are less affected. This allows for higher doses of therapeutic agents to be used, increasing the likelihood of eradicating cancer cells. Additionally, selective targeting can improve the overall quality of life for patients by minimizing the physical and psychological burden of treatment.
